On January 23, 2018, POLUS BioPharm Inc. (KOSE:A007630) closed the transaction. The company announced that it has issued 7,194,244 shares for gross proceeds of KRW 29,999,997,480 in its second tranche. The company received KRW 72,499,997,480 in funding so far in the transaction.